451 related articles for article (PubMed ID: 10415058)
1. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
[TBL] [Abstract][Full Text] [Related]
2. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.
Olze H; Förster U; Zuberbier T; Morawietz L; Luger EO
Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics.
Ying S; Meng Q; Zeibecoglou K; Robinson DS; Macfarlane A; Humbert M; Kay AB
J Immunol; 1999 Dec; 163(11):6321-9. PubMed ID: 10570327
[TBL] [Abstract][Full Text] [Related]
6. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
[TBL] [Abstract][Full Text] [Related]
7. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis.
Taha RA; Minshall EM; Leung DY; Boguniewicz M; Luster A; Muro S; Toda M; Hamid QA
J Allergy Clin Immunol; 2000 May; 105(5):1002-7. PubMed ID: 10808183
[TBL] [Abstract][Full Text] [Related]
8. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression.
Bartels J; Maune S; Meyer JE; Kulke R; Schlüter C; Röwert J; Christophers E; Schröder JM
Rhinology; 1997 Dec; 35(4):171-4. PubMed ID: 9532637
[TBL] [Abstract][Full Text] [Related]
9. [The role of chemokines in nasal polyps].
Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells.
Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; Springer MS; Durham SR; Williams TJ; Kay AB
Eur J Immunol; 1997 Dec; 27(12):3507-16. PubMed ID: 9464841
[TBL] [Abstract][Full Text] [Related]
11. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
[TBL] [Abstract][Full Text] [Related]
13. Bovine eotaxin (CCL11)--an unusual member of the eotaxin group--attracts eosinophils in vitro but is not responsible for eosinophilia in the ovary.
Vogel B; Klinder A; Sittig D; Aust G
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):67-77. PubMed ID: 15916812
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A
Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3.
Saito H; Honda K; Asaka C; Ueki S; Ishikawa K
Allergol Int; 2016 Jul; 65(3):280-5. PubMed ID: 26874579
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
17. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad.
Pods R; Ross D; van Hülst S; Rudack C; Maune S
Allergy; 2003 Nov; 58(11):1165-70. PubMed ID: 14616128
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps.
Seto H; Suzaki H; Shioda S
Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046
[TBL] [Abstract][Full Text] [Related]
20. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
